Telcagepant does not reduce exercise tolerance in patients with exercise induced myocardial ischemia

Authors
Ho A.P.1 , Chaitman B.R.2 , Behm M.O.1 , Rowe J.F.1 , Palcza J.S.1 , Laethem T.3 , Heirman I.3 , Panebianco D.L.1 , Moiseev V.S. 4 , Martsevich S.Y.5 , Free A.L.6 , Bittar N.7 , Chrysant S.G.8 , Kobalava Z.D. 4 , Ho T.W.1 , Chodakewitz J.A.1 , Murphy M.G.1 , Blanchard R.L.1
Conference proceedings
JOURNAL OF HEADACHE AND PAIN
Publisher
SPRINGER-VERLAG ITALIA SRL
Language
English
Status
Published
Volume
11
Year
2010
Organizations
  • 1 Merck & Co Inc, N Wales, PA USA
  • 2 St Louis Univ, Sch Med, Div Cardiol, St Louis, MO USA
  • 3 MSD, Brussels, Belgium
  • 4 Russian Peoples Friendship Univ, Ctr Appl Clin Pharmacol, Moscow, Russia
  • 5 FGU State Sci Res Ctr Prophylact Med Rosmedtechno, Moscow, Russia
  • 6 Pinnacle Res Grp, Anniston, AL USA
  • 7 Gemini Sci, Madison, WI USA
  • 8 Univ Oklahoma, Oklahoma Cardiovasc & Hypertens Ctr, Oklahoma City, OK USA
Date of creation
19.10.2018
Date of change
19.10.2018
Short link
https://repository.rudn.ru/en/records/article/record/8584/
Share

Other records